APA (7th ed.) Citation

Shahrokh, S., Namazi, N., Abbasinazari, M., Abazarikia, A., Sadeghi, A., & Mahboubi, A. (2025). Assessment of the Efficacy and Safety of Sublingual Melatonin on Symptom Severity, Quality of Life, and Sleep Disorders in Patients with Irritable Bowel Syndrome. IJ Pharmaceutical Research (IJPR), 24(1), 1. https://doi.org/10.5812/ijpr-156425

Chicago Style (17th ed.) Citation

Shahrokh, Shabnam, Niloofar Namazi, Mohammad Abbasinazari, Ali Abazarikia, Amir Sadeghi, and Arash Mahboubi. "Assessment of the Efficacy and Safety of Sublingual Melatonin on Symptom Severity, Quality of Life, and Sleep Disorders in Patients with Irritable Bowel Syndrome." IJ Pharmaceutical Research (IJPR) 24, no. 1 (2025): 1. https://doi.org/10.5812/ijpr-156425.

MLA (9th ed.) Citation

Shahrokh, Shabnam, et al. "Assessment of the Efficacy and Safety of Sublingual Melatonin on Symptom Severity, Quality of Life, and Sleep Disorders in Patients with Irritable Bowel Syndrome." IJ Pharmaceutical Research (IJPR), vol. 24, no. 1, 2025, p. 1, https://doi.org/10.5812/ijpr-156425.